Extensive impairment of triazolam and alprazolam clearance by short-term low-dose ritonavir: The clinical dilemma of concurrent inhibition and induction

被引：47

作者：

Greenblatt, DJ ^{[1
]}

von Moltke, LL

Daily, JP

Harmatz, JS

Shader, RI

机构：

[1] Tufts Univ, Sch Med, Boston, MA 02111 USA

[2] Harvard Univ, Sch Med, Boston, MA USA

[3] Brigham & Womens Hosp, Boston, MA 02115 USA

来源：

JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY | 1999年 / 19卷 / 04期

关键词：

D O I：

10.1097/00004714-199908000-00001

中图分类号：

R9 [药学];

学科分类号：

1007 ;

摘要：

引用

页码：293 / 296

页数：4

共 51 条

[1] Active apical secretory efflux of the HIV protease inhibitors saquinavir and ritonavir in Caco-2 cell monolayers [J].

Alsenz, J ;

Steffen, H ;

Alex, R .

PHARMACEUTICAL RESEARCH, 1998, 15 (03) :423-428

[2] Antiretroviral therapy for patients with HIV disease [J].

Barry, M ;

Mulcahy, F ;

Back, DJ .

BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 1998, 45 (03) :221-228

[3] Protease inhibitors in patients with HIV disease - Clinically important pharmacokinetic considerations [J].

Barry, M ;

Gibbons, S ;

Back, D ;

Mulcahy, F .

CLINICAL PHARMACOKINETICS, 1997, 32 (03) :194-209

[4] Reconsidering targeted toxins to eliminate HIV infection: You gotta have HAART [J].

Berger, EA ;

Moss, B ;

Pastan, I .

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1998, 95 (20) :11511-11513

[5] Assessment of the potential for a pharmacokinetic interaction between fluoxetine and terfenadine [J].

Bergstrom, RF ;

Goldberg, MJ ;

Cerimele, BJ ;

Hatcher, BL .

CLINICAL PHARMACOLOGY & THERAPEUTICS, 1997, 62 (06) :643-651

[6] Use of in vitro and in vivo data to estimate the likelihood of metabolic pharmacokinetic interactions [J].

Bertz, RJ ;

Granneman, GR .

CLINICAL PHARMACOKINETICS, 1997, 32 (03) :210-258

[7] Antiretroviral therapy for HIV infection in 1998 - Updated recommendations of the International AIDS Society USA panel [J].

Carpenter, CCJ ;

Fischl, MA ;

Hammer, SM ;

Hirsch, MS ;

Jacobsen, DM ;

Katzenstein, DA ;

Montaner, JSG ;

Richman, DD ;

Saag, MS ;

Schooley, RT ;

Thompson, MA ;

Vella, S ;

Yeni, PG ;

Volberding, PA .

JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1998, 280 (01) :78-86

[8]

Chuck SK, 1999, AIDS PREVENT MENT H, P33

[9] Differential inhibition of cytochrome P450 isoforms by the protease inhibitors, ritonavir, saquinavir and indinavir [J].

Eagling, VA ;

Back, DJ ;

Barry, MG .

BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 1997, 44 (02) :190-194

[10] HIV-protease inhibitors [J].

Flexner, C .

NEW ENGLAND JOURNAL OF MEDICINE, 1998, 338 (18) :1281-1292

← 1 2 3 4 5 6 →